According to this latest study, the 2021 growth of Diagnostic Radiopharmaceuticals will have significant change from previous year. By the most conservative estimates of global Diagnostic Radiopharmaceuticals market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 4012.8 million in 2020. Over the next five years the Diagnostic Radiopharmaceuticals market will register a 7.2% CAGR in terms of revenue, the global market size will reach US$ 5291 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Technetium 99

Fluorine 18

Other

Diagnostic radiopharmaceuticals are mainly divided into technetium 99, fluorine 18 and others. Among them, technetium 99 accounted for the main part, accounting for about 47.56% of the total market in 2019.

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Oncology

Cardiology

Other

Diagnostic radiopharmaceutical applications are mainly for oncology, cardiology and others. Among them, oncology accounts for the main part, accounting for about 45.8% of the total market in 2019.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Cardinal Health

GE Healthcare

Curium Pharma

Jubilant Pharma

Bracco Imaging

Advanced Accelerator Applications

SIEMENS

China Isotope & Radiation

Dongcheng Pharmaceutical Group

Lantheus

Eli Lilly

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Diagnostic Radiopharmaceuticals Consumption 2016-2026

2.1.2 Diagnostic Radiopharmaceuticals Consumption CAGR by Region

2.2 Diagnostic Radiopharmaceuticals Segment by Type

2.2.1 Technetium 99

2.2.2 Fluorine 18

2.2.3 Other

2.3 Diagnostic Radiopharmaceuticals Sales by Type

2.3.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)

2.3.2 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Type (2016-2021)

2.3.3 Global Diagnostic Radiopharmaceuticals Sale Price by Type (2016-2021)

2.4 Diagnostic Radiopharmaceuticals Segment by Application

2.4.1 Oncology

2.4.2 Cardiology

2.4.3 Other

2.5 Diagnostic Radiopharmaceuticals Sales by Application

2.5.1 Global Diagnostic Radiopharmaceuticals Sale Market Share by Application (2016-2021)

2.5.2 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Application (2016-2021)

2.5.3 Global Diagnostic Radiopharmaceuticals Sale Price by Application (2016-2021)

3 Global Diagnostic Radiopharmaceuticals by Company

3.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Company

3.1.1 Global Diagnostic Radiopharmaceuticals Sales by Company (2019-2021)

3.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Company (2019-2021)

3.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company

3.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Company (2019-2021)

3.2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2019-2021)

3.3 Global Diagnostic Radiopharmaceuticals Sale Price by Company

3.4 Global Manufacturers Diagnostic Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Diagnostic Radiopharmaceuticals Product Location Distribution

3.4.2 Players Diagnostic Radiopharmaceuticals Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Diagnostic Radiopharmaceuticals by Region

4.1 Global Diagnostic Radiopharmaceuticals by Region

4.1.1 Global Diagnostic Radiopharmaceuticals Sales by Region

4.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Region

4.2 Americas Diagnostic Radiopharmaceuticals Sales Growth

4.3 APAC Diagnostic Radiopharmaceuticals Sales Growth

4.4 Europe Diagnostic Radiopharmaceuticals Sales Growth

4.5 Middle East & Africa Diagnostic Radiopharmaceuticals Sales Growth

5 Americas

5.1 Americas Diagnostic Radiopharmaceuticals Sales by Country

5.1.1 Americas Diagnostic Radiopharmaceuticals Sales by Country (2016-2021)

5.1.2 Americas Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021)

5.2 Americas Diagnostic Radiopharmaceuticals Sales by Type

5.3 Americas Diagnostic Radiopharmaceuticals Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Diagnostic Radiopharmaceuticals Sales by Region

6.1.1 APAC Diagnostic Radiopharmaceuticals Sales by Region (2016-2021)

6.1.2 APAC Diagnostic Radiopharmaceuticals Revenue by Region (2016-2021)

6.2 APAC Diagnostic Radiopharmaceuticals Sales by Type

6.3 APAC Diagnostic Radiopharmaceuticals Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Diagnostic Radiopharmaceuticals by Country

7.1.1 Europe Diagnostic Radiopharmaceuticals Sales by Country (2016-2021)

7.1.2 Europe Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021)

7.2 Europe Diagnostic Radiopharmaceuticals Sales by Type

7.3 Europe Diagnostic Radiopharmaceuticals Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Diagnostic Radiopharmaceuticals by Country

8.1.1 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Country (2016-2021)

8.1.2 Middle East & Africa Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021)

8.2 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Type

8.3 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Diagnostic Radiopharmaceuticals Distributors

10.3 Diagnostic Radiopharmaceuticals Customer

11 Global Diagnostic Radiopharmaceuticals Market Forecast

11.1 Global Diagnostic Radiopharmaceuticals Forecast by Region

11.1.1 Global Diagnostic Radiopharmaceuticals Forecast by Regions (2021-2026)

11.2.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Diagnostic Radiopharmaceuticals Forecast by Type

11.7 Global Diagnostic Radiopharmaceuticals Forecast by Application

12 Key Players Analysis

12.1 Cardinal Health

12.1.1 Cardinal Health Company Information

12.1.2 Cardinal Health Diagnostic Radiopharmaceuticals Product Offered

12.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Cardinal Health Main Business Overview

12.1.5 Cardinal Health Latest Developments

12.2 GE Healthcare

12.2.1 GE Healthcare Company Information

12.2.2 GE Healthcare Diagnostic Radiopharmaceuticals Product Offered

12.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 GE Healthcare Main Business Overview

12.2.5 GE Healthcare Latest Developments

12.3 Curium Pharma

12.3.1 Curium Pharma Company Information

12.3.2 Curium Pharma Diagnostic Radiopharmaceuticals Product Offered

12.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Curium Pharma Main Business Overview

12.3.5 Curium Pharma Latest Developments

12.4 Jubilant Pharma

12.4.1 Jubilant Pharma Company Information

12.4.2 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Offered

12.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Jubilant Pharma Main Business Overview

12.4.5 Jubilant Pharma Latest Developments

12.5 Bracco Imaging

12.5.1 Bracco Imaging Company Information

12.5.2 Bracco Imaging Diagnostic Radiopharmaceuticals Product Offered

12.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Bracco Imaging Main Business Overview

12.5.5 Bracco Imaging Latest Developments

12.6 Advanced Accelerator Applications

12.6.1 Advanced Accelerator Applications Company Information

12.6.2 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Offered

12.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Advanced Accelerator Applications Main Business Overview

12.6.5 Advanced Accelerator Applications Latest Developments

12.7 SIEMENS

12.7.1 SIEMENS Company Information

12.7.2 SIEMENS Diagnostic Radiopharmaceuticals Product Offered

12.7.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 SIEMENS Main Business Overview

12.7.5 SIEMENS Latest Developments

12.8 China Isotope & Radiation

12.8.1 China Isotope & Radiation Company Information

12.8.2 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Offered

12.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 China Isotope & Radiation Main Business Overview

12.8.5 China Isotope & Radiation Latest Developments

12.9 Dongcheng Pharmaceutical Group

12.9.1 Dongcheng Pharmaceutical Group Company Information

12.9.2 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Offered

12.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Dongcheng Pharmaceutical Group Main Business Overview

12.9.5 Dongcheng Pharmaceutical Group Latest Developments

12.10 Lantheus

12.10.1 Lantheus Company Information

12.10.2 Lantheus Diagnostic Radiopharmaceuticals Product Offered

12.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Lantheus Main Business Overview

12.10.5 Lantheus Latest Developments

12.11 Eli Lilly

12.11.1 Eli Lilly Company Information

12.11.2 Eli Lilly Diagnostic Radiopharmaceuticals Product Offered

12.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Eli Lilly Main Business Overview

12.11.5 Eli Lilly Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Diagnostic Radiopharmaceuticals Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Technetium 99

Table 3. Major Players of Fluorine 18

Table 4. Major Players of Other

Table 5. Global Diagnostic Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)

Table 6. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)

Table 7. Global Diagnostic Radiopharmaceuticals Revenue by Type (2016-2021) & ($ million)

Table 8. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2016-2021)

Table 9. Global Diagnostic Radiopharmaceuticals Sale Price by Type (2016-2021)

Table 10. Global Diagnostic Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)

Table 11. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)

Table 12. Global Diagnostic Radiopharmaceuticals Value by Application (2016-2021)

Table 13. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2016-2021)

Table 14. Global Diagnostic Radiopharmaceuticals Sale Price by Application (2016-2021)

Table 15. Global Diagnostic Radiopharmaceuticals Sales by Company (2019-2021) & (K Units)

Table 16. Global Diagnostic Radiopharmaceuticals Sales Market Share by Company (2019-2021)

Table 17. Global Diagnostic Radiopharmaceuticals Revenue by Company (2019-2021) ($ Millions)

Table 18. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2019-2021)

Table 19. Global Diagnostic Radiopharmaceuticals Sale Price by Company (2019-2021)

Table 20. Key Manufacturers Diagnostic Radiopharmaceuticals Producing Area Distribution and Sales Area

Table 21. Players Diagnostic Radiopharmaceuticals Products Offered

Table 22. Diagnostic Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Diagnostic Radiopharmaceuticals Sales by Region (2016-2021) (K Units)

Table 26. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2016-2021)

Table 27. Global Diagnostic Radiopharmaceuticals Revenue by Region (2016-2021) & ($ Millions)

Table 28. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2016-2021)

Table 29. Americas Diagnostic Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)

Table 30. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Country (2016-2021)

Table 31. Americas Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)

Table 32. Americas Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2016-2021)

Table 33. Americas Diagnostic Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)

Table 34. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)

Table 35. Americas Diagnostic Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)

Table 36. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)

Table 37. APAC Diagnostic Radiopharmaceuticals Sales by Region (2016-2021) & (K Units)

Table 38. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Region (2016-2021)

Table 39. APAC Diagnostic Radiopharmaceuticals Revenue by Region (2016-2021) & ($ Millions)

Table 40. APAC Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2016-2021)

Table 41. APAC Diagnostic Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)

Table 42. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)

Table 43. APAC Diagnostic Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)

Table 44. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)

Table 45. Europe Diagnostic Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)

Table 46. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country (2016-2021)

Table 47. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)

Table 48. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2016-2021)

Table 49. Europe Diagnostic Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)

Table 50. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)

Table 51. Europe Diagnostic Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)

Table 52. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)

Table 53. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)

Table 54. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country (2016-2021)

Table 55. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)

Table 56. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2016-2021)

Table 57. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)

Table 58. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)

Table 59. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)

Table 60. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)

Table 61. Key and Potential Regions of Diagnostic Radiopharmaceuticals

Table 62. Key Application and Potential Industries of Diagnostic Radiopharmaceuticals

Table 63. Key Challenges of Diagnostic Radiopharmaceuticals

Table 64. Key Trends of Diagnostic Radiopharmaceuticals

Table 65. Diagnostic Radiopharmaceuticals Distributors List

Table 66. Diagnostic Radiopharmaceuticals Customer List

Table 67. Global Diagnostic Radiopharmaceuticals Sales Forecast by Region (2021-2026) & (K Units)

Table 68. Global Diagnostic Radiopharmaceuticals Consumption Market Forecast by Region

Table 69. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2021-2026) & ($ millions)

Table 70. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Region (2021-2026)

Table 71. Americas Diagnostic Radiopharmaceuticals Sales Forecast by Country (2021-2026) & (K Units)

Table 72. Americas Diagnostic Radiopharmaceuticals Revenue Forecast by Country (2021-2026) & ($ millions)

Table 73. APAC Diagnostic Radiopharmaceuticals Sales Forecast by Region (2021-2026) & (K Units)

Table 74. APAC Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2021-2026) & ($ millions)

Table 75. Europe Diagnostic Radiopharmaceuticals Sales Forecast by Country (2021-2026) & (K Units)

Table 76. Europe Diagnostic Radiopharmaceuticals Revenue Forecast by Country (2021-2026) & ($ millions)

Table 77. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Forecast by Country (2021-2026) & (K Units)

Table 78. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue Forecast by Country (2021-2026) & ($ millions)

Table 79. Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2021-2026) & (K Units)

Table 80. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Type (2021-2026)

Table 81. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 82. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Type (2021-2026)

Table 83. Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2021-2026) & (K Units)

Table 84. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Application (2021-2026)

Table 85. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 86. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Application (2021-2026)

Table 87. Cardinal Health Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 88. Cardinal Health Diagnostic Radiopharmaceuticals Product Offered

Table 89. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 90. Cardinal Health Main Business

Table 91. Cardinal Health Latest Developments

Table 92. GE Healthcare Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 93. GE Healthcare Diagnostic Radiopharmaceuticals Product Offered

Table 94. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 95. GE Healthcare Main Business

Table 96. GE Healthcare Latest Developments

Table 97. Curium Pharma Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 98. Curium Pharma Diagnostic Radiopharmaceuticals Product Offered

Table 99. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 100. Curium Pharma Main Business

Table 101. Curium Pharma Latest Developments

Table 102. Jubilant Pharma Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 103. Jubilant Pharma Diagnostic Radiopharmaceuticals Product Offered

Table 104. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 105. Jubilant Pharma Main Business

Table 106. Jubilant Pharma Latest Developments

Table 107. Bracco Imaging Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 108. Bracco Imaging Diagnostic Radiopharmaceuticals Product Offered

Table 109. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 110. Bracco Imaging Main Business

Table 111. Bracco Imaging Latest Developments

Table 112. Advanced Accelerator Applications Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 113. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Offered

Table 114. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 115. Advanced Accelerator Applications Main Business

Table 116. Advanced Accelerator Applications Latest Developments

Table 117. SIEMENS Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 118. SIEMENS Diagnostic Radiopharmaceuticals Product Offered

Table 119. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 120. SIEMENS Main Business

Table 121. SIEMENS Latest Developments

Table 122. China Isotope & Radiation Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 123. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Offered

Table 124. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 125. China Isotope & Radiation Main Business

Table 126. China Isotope & Radiation Latest Developments

Table 127. Dongcheng Pharmaceutical Group Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 128. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Offered

Table 129. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 130. Dongcheng Pharmaceutical Group Main Business

Table 131. Dongcheng Pharmaceutical Group Latest Developments

Table 132. Lantheus Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 133. Lantheus Diagnostic Radiopharmaceuticals Product Offered

Table 134. Lantheus Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 135. Lantheus Main Business

Table 136. Lantheus Latest Developments

Table 137. Eli Lilly Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 138. Eli Lilly Diagnostic Radiopharmaceuticals Product Offered

Table 139. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 140. Eli Lilly Main Business

Table 141. Eli Lilly Latest Developments

List of Figures

Figure 1. Picture of Diagnostic Radiopharmaceuticals

Figure 2. Diagnostic Radiopharmaceuticals Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Diagnostic Radiopharmaceuticals Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Diagnostic Radiopharmaceuticals Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Diagnostic Radiopharmaceuticals Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Technetium 99

Figure 10. Product Picture of Fluorine 18

Figure 11. Product Picture of Other

Figure 12. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2020

Figure 13. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2016-2021)

Figure 14. Diagnostic Radiopharmaceuticals Consumed in Oncology

Figure 15. Global Diagnostic Radiopharmaceuticals Market: Oncology (2016-2021) & (K Units)

Figure 16. Diagnostic Radiopharmaceuticals Consumed in Cardiology

Figure 17. Global Diagnostic Radiopharmaceuticals Market: Cardiology (2016-2021) & (K Units)

Figure 18. Diagnostic Radiopharmaceuticals Consumed in Other

Figure 19. Global Diagnostic Radiopharmaceuticals Market: Other (2016-2021) & (K Units)

Figure 20. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)

Figure 21. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application in 2020

Figure 22. Diagnostic Radiopharmaceuticals Revenue Market by Company in 2020 ($ Million)

Figure 23. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company in 2020

Figure 24. Global Diagnostic Radiopharmaceuticals Sales Market Share by Regions (2016-2021)

Figure 25. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region in 2020

Figure 26. Americas Diagnostic Radiopharmaceuticals Sales 2016-2021 (K Units)

Figure 27. Americas Diagnostic Radiopharmaceuticals Revenue 2016-2021 ($ Millions)

Figure 28. APAC Diagnostic Radiopharmaceuticals Sales 2016-2021 (K Units)

Figure 29. APAC Diagnostic Radiopharmaceuticals Revenue 2016-2021 ($ Millions)

Figure 30. Europe Diagnostic Radiopharmaceuticals Sales 2016-2021 (K Units)

Figure 31. Europe Diagnostic Radiopharmaceuticals Revenue 2016-2021 ($ Millions)

Figure 32. Middle East & Africa Diagnostic Radiopharmaceuticals Sales 2016-2021 (K Units)

Figure 33. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue 2016-2021 ($ Millions)

Figure 34. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2020

Figure 35. Americas Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2020

Figure 36. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2020

Figure 37. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2020

Figure 38. United States Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 39. Canada Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 40. Mexico Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 41. Brazil Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 42. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2020

Figure 43. APAC Diagnostic Radiopharmaceuticals Revenue Market Share by Regions in 2020

Figure 44. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2020

Figure 45. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2020

Figure 46. China Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 47. Japan Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 48. Korea Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 49. Southeast Asia Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 50. India Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 51. Australia Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 52. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2020

Figure 53. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2020

Figure 54. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2020

Figure 55. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2020

Figure 56. Germany Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 57. France Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 58. UK Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 59. Italy Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 60. Russia Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 61. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2020

Figure 62. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2020

Figure 63. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2020

Figure 64. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2020

Figure 65. Egypt Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 66. South Africa Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 67. Israel Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 68. Turkey Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 69. GCC Country Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles